Invention Grant
- Patent Title: C-terminal fragment of tetanus toxin (HC) for treatment of depression
-
Application No.: US17729502Application Date: 2022-04-26
-
Publication No.: US12168035B2Publication Date: 2024-12-17
- Inventor: Yousef Tizabi
- Applicant: HOWARD UNIVERSITY
- Applicant Address: US DC Washington
- Assignee: HOWARD UNIVERSITY
- Current Assignee: HOWARD UNIVERSITY
- Current Assignee Address: US DC Washington
- Agency: Sughrue Mion, PLLC
- Main IPC: A61K38/16
- IPC: A61K38/16 ; A61K9/00

Abstract:
C-terminal domain of the heavy chain of tetanus toxin (Hc-TeTx) provides therapeutic effects in motor impairments associated with Parkinson disease (PD), and provides long lasting antidepressant effects, thus useful in treating and mitigating depression, particularly PD-depression co-morbid condition. A method for treating or mitigating depression, including administrating an effective amount of C-terminal domain of the heavy chain of tetanus toxin (Hc-TeTx) to a subject in need thereof. A method for treating or mitigating motor impairments associated with Parkinson's disease (PD), including administrating an effective amount of C-terminal domain of the heavy chain of tetanus toxin (Hc-TeTx) to a subject in need thereof.
Public/Granted literature
- US20220249602A1 C-TERMINAL FRAGMENT OF TETANUS TOXIN (HC) FOR TREATMENT OF DEPRESSION Public/Granted day:2022-08-11
Information query
IPC分类: